16.04.2020 | Article
BCG is seen as a possible ‘game changer’ in COVID-19 treatment
By Nathan Cripps
11.03.2020 | Article
FDA Tracker: HCPs share migraine and heart treatment approvals
By Nathan Cripps
11.02.2020 | Article
FDA Tracker: Novo Nordisk’s Ozempic and Rybelsus the most mentioned approvals
By Nathan Cripps
14.01.2020 | Article
FDA Tracker: HCPs excited for Keytruda® approval but share reservations about Vascepa®
By Nathan Cripps
13.12.2019 | Article
FDA Tracker: Oxbryt and Tecentriq discussed the most by healthcare professionals in November
By Nathan Cripps
14.11.2019 | Article
‘A new hope’ found in the FDA approvals of Entresto and Farxiga
By Nathan Cripps
17.10.2019 | Article
Game changing' month as Erleada® and Rybelsus® approved by the FDA
By Nathan Cripps
07.10.2019 | Article
It has been noted that the opioid crisis, which is the result of the misuse of opioids
By Nathan Cripps
13.09.2019 | Article
Rinvoq and Pretomanid spark HCP interest after gaining FDA approval
By Nathan Cripps
19.06.2019 | Article
What US healthcare professionals were thinking about pancreatic cancer during #ASCO19
By Nathan Cripps
15.04.2019 | Article
Healthcare professionals excited by emerging treatments for prostate cancer
By Nathan Cripps